Targeting ferroptosis as a vulnerability in pulmonary diseases

Area of Science:

• Biomedical Science
• Cell Biology
• Pathology

Background:

• Ferroptosis is a regulated cell death pathway driven by iron accumulation and lipid peroxidation.
• Oxidative stress leads to the accumulation of excessive oxidative phospholipids (PLs), particularly those containing polyunsaturated fatty acids (PUFA-PLs).
• Ferroptosis plays a significant role in the development and progression of various pulmonary diseases.

Purpose of the Study:

• To review the role of ferroptosis in the pathogenesis of key pulmonary diseases.
• To explore the potential of targeting ferroptosis as a therapeutic strategy for lung conditions.

Main Methods:

• Literature review of studies on ferroptosis and pulmonary diseases.
• Analysis of the mechanisms linking ferroptosis to disease pathogenesis.
• Evaluation of therapeutic strategies targeting ferroptosis.

Main Results:

• Ferroptosis is implicated in the pathogenesis of asthma, lung injury, lung cancer, fibrotic lung diseases, and pulmonary infections.
• Targeting ferroptosis presents a potential therapeutic avenue for pulmonary diseases.
• This approach may be particularly effective against drug-resistant lung cancer and antibiotic-resistant pulmonary infections.

Conclusions:

• Ferroptosis is a critical factor in the development of numerous pulmonary diseases.
• Targeting ferroptosis offers a novel therapeutic strategy for lung diseases, with potential benefits for drug-resistant conditions and reduced adverse events.